Stromal Vascular Fraction Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Report
183 Pages
December 2023
Region: Global
Fairfield Market Research
ID: 5918269

The global Stromal Vascular Fraction (SVF) market, with revenues of approximately US$ 96 million in 2024, is on track to achieve a valuation of around US$ 131 million by the end of 2031. The market's growth is being driven by the development of new automated Point-of-Care (POC) devices, cost-effectiveness, and the rising adoption of SVF therapies.

Driving Growth: Development of Automated POC Devices

Stem cell therapies, including SVF procedures, hold great promise in healthcare. However, the practical implementation of SVF therapies faces challenges in terms of knowledge, infrastructure, and supplies in many healthcare facilities. To overcome these obstacles, companies and research laboratories are developing automated POC devices to streamline SVF isolation processes. These devices eliminate the need for transport, reduce processing costs, and offer significant advantages in terms of minimal manipulation of tissue. Cost savings, ease of use, and improved patient outcomes are key drivers of market growth.

Challenges: Regulatory Compliance and Infrastructure

Challenges to SVF market growth include regulatory compliance issues and the need for advanced infrastructure. In the past, some medical device companies pushed products beyond regulatory boundaries, impacting patient perceptions and adoption of adipose-derived stem cell therapies. Compliance with regulations is critical to ensure patient safety.

Infrastructure requirements, such as clean room facilities, specialized equipment, technical capabilities, and adherence to cGMP practices, limit SVF implementation to major hospitals in urban areas. Obtaining reimbursement for these procedures remains challenging, reducing market penetration.

Country-wise Insights

United States: Extensive Clinical Trials Fuel Demand

The U.S. market is booming due to a massive pipeline of SVF-derived cell therapies and extensive clinical trials assessing their efficacy for various purposes. The increasing number of clinical trials drives demand for SVF products, including proprietary SVF isolation devices and consumables.

India: Rise in Research and Development Activities

India is emerging as a lucrative market due to increased research and development activities focused on innovative SVF technologies. The expansion of private hospitals in rural areas contributes to market growth, making the Asian region attractive.

Germany: Musculoskeletal Disorders Drive Demand

Germany's growing aging population and rising awareness of stem cell therapy, particularly in musculoskeletal disorders like osteoarthritis, position the country as a prominent market for SVF treatments. Legal constraints on stem-cell research and therapy are expected to relax, further boosting market growth.

Competitive Landscape

Key market players emphasize product launches, strategic alliances, mergers, acquisitions, and facility expansions to enhance their market presence.

Key Companies in the Stromal Vascular Fraction (SVF) Market:

Cytori Therapeutics Inc.
IntelliCell BioSciences Inc.
Cellular Biomedicines Group, Inc.
GE Healthcare (Biosafe Group SA)
Lifecell Corporation (Allergen PLC)
Tissue Genesis Inc.
InGeneron, Inc.
Human med AG
MEDICAN CO., LTD
Hairline International
Genesis Biosystems, Inc.
iXCells Biotechnologies USA, LLC
Kyocera Corporation
Medikan International Inc.

Key Segments Covered in Manufacturing of Industry Research

Product:

SVF Aspiration Products
SVF Transfer Products
SVF Isolation Products
Enzymatic Isolation Products
Non-enzymatic Isolation Products
Automated POC Devices

Application:

Cosmetic Applications
Orthopedic Applications
Soft Tissue Applications
Others

End User:

Hospitals
Specialty Clinics
Stem Cell Banks/Laboratories
Others

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
The Middle East & Africa (MEA)

This product will be delivered within 1-3 business days.

1. Executive Summary

1.1. Global Stromal Vascular Fraction Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Stromal Vascular Fraction Market Outlook, 2018 - 2031

3.1. Global Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. SVF Aspiration Products
3.1.1.2. SVF Transfer Products
3.1.1.3. SVF Isolation Products
3.1.1.3.1. Enzymatic Isolation Products
3.1.1.3.2. Non-enzymatic Isolation Products
3.1.1.3.3. Automated POC Devices
3.2. Global Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Cosmetic Applications
3.2.1.2. Orthopedic Applications
3.2.1.3. Soft Tissue Applications
3.2.1.4. Others
3.3. Global Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Hospitals
3.3.1.2. Specialty Clinics
3.3.1.3. Stem Cell Banks/Laboratories
3.3.1.4. Others
3.4. Global Stromal Vascular Fraction Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa

4. North America Stromal Vascular Fraction Market Outlook, 2018 - 2031

4.1. North America Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. SVF Aspiration Products
4.1.1.2. SVF Transfer Products
4.1.1.3. SVF Isolation Products
4.1.1.3.1. Enzymatic Isolation Products
4.1.1.3.2. Non-enzymatic Isolation Products
4.1.1.3.3. Automated POC Devices
4.2. North America Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Cosmetic Applications
4.2.1.2. Orthopedic Applications
4.2.1.3. Soft Tissue Applications
4.2.1.4. Others
4.3. North America Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Hospitals
4.3.1.2. Specialty Clinics
4.3.1.3. Stem Cell Banks/Laboratories
4.3.1.4. Others
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
4.4.1.2. U.S. Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
4.4.1.3. U.S. Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
4.4.1.4. Canada Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
4.4.1.5. Canada Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
4.4.1.6. Canada Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Stromal Vascular Fraction Market Outlook, 2018 - 2031

5.1. Europe Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. SVF Aspiration Products
5.1.1.2. SVF Transfer Products
5.1.1.3. SVF Isolation Products
5.1.1.3.1. Enzymatic Isolation Products
5.1.1.3.2. Non-enzymatic Isolation Products
5.1.1.3.3. Automated POC Devices
5.2. Europe Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Cosmetic Applications
5.2.1.2. Orthopedic Applications
5.2.1.3. Soft Tissue Applications
5.2.1.4. Others
5.3. Europe Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospitals
5.3.1.2. Specialty Clinics
5.3.1.3. Stem Cell Banks/Laboratories
5.3.1.4. Others
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
5.4.1.2. Germany Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.3. Germany Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.4. U.K. Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
5.4.1.5. U.K. Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.6. U.K. Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.7. France Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
5.4.1.8. France Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.9. France Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.10. Italy Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
5.4.1.11. Italy Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.12. Italy Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.13. Turkey Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
5.4.1.14. Turkey Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.15. Turkey Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.16. Russia Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
5.4.1.17. Russia Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.18. Russia Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
5.4.1.19. Rest of Europe Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
5.4.1.20. Rest of Europe Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
5.4.1.21. Rest of Europe Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Stromal Vascular Fraction Market Outlook, 2018 - 2031

6.1. Asia Pacific Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. SVF Aspiration Products
6.1.1.2. SVF Transfer Products
6.1.1.3. SVF Isolation Products
6.1.1.3.1. Enzymatic Isolation Products
6.1.1.3.2. Non-enzymatic Isolation Products
6.1.1.3.3. Automated POC Devices
6.2. Asia Pacific Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Cosmetic Applications
6.2.1.2. Orthopedic Applications
6.2.1.3. Soft Tissue Applications
6.2.1.4. Others
6.3. Asia Pacific Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospitals
6.3.1.2. Specialty Clinics
6.3.1.3. Stem Cell Banks/Laboratories
6.3.1.4. Others
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. China Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
6.4.1.2. China Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
6.4.1.3. China Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.4. Japan Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
6.4.1.5. Japan Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
6.4.1.6. Japan Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.7. South Korea Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
6.4.1.8. South Korea Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
6.4.1.9. South Korea Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.10. India Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
6.4.1.11. India Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
6.4.1.12. India Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.13. Southeast Asia Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
6.4.1.14. Southeast Asia Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
6.4.1.15. Southeast Asia Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
6.4.1.16. Rest of Asia Pacific Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
6.4.1.17. Rest of Asia Pacific Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
6.4.1.18. Rest of Asia Pacific Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Stromal Vascular Fraction Market Outlook, 2018 - 2031

7.1. Latin America Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. SVF Aspiration Products
7.1.1.2. SVF Transfer Products
7.1.1.3. SVF Isolation Products
7.1.1.3.1. Enzymatic Isolation Products
7.1.1.3.2. Non-enzymatic Isolation Products
7.1.1.3.3. Automated POC Devices
7.2. Latin America Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
7.2.1.1. Cosmetic Applications
7.2.1.2. Orthopedic Applications
7.2.1.3. Soft Tissue Applications
7.2.1.4. Others
7.3. Latin America Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Hospitals
7.3.1.2. Specialty Clinics
7.3.1.3. Stem Cell Banks/Laboratories
7.3.1.4. Others
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
7.4.1.2. Brazil Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
7.4.1.3. Brazil Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
7.4.1.4. Mexico Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
7.4.1.5. Mexico Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
7.4.1.6. Mexico Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
7.4.1.7. Argentina Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
7.4.1.8. Argentina Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
7.4.1.9. Argentina Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
7.4.1.10. Rest of Latin America Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
7.4.1.11. Rest of Latin America Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
7.4.1.12. Rest of Latin America Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Stromal Vascular Fraction Market Outlook, 2018 - 2031

8.1. Middle East & Africa Stromal Vascular Fraction Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. SVF Aspiration Products
8.1.1.2. SVF Transfer Products
8.1.1.3. SVF Isolation Products
8.1.1.3.1. Enzymatic Isolation Products
8.1.1.3.2. Non-enzymatic Isolation Products
8.1.1.3.3. Automated POC Devices
8.2. Middle East & Africa Stromal Vascular Fraction Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Cosmetic Applications
8.2.1.2. Orthopedic Applications
8.2.1.3. Soft Tissue Applications
8.2.1.4. Others
8.3. Middle East & Africa Stromal Vascular Fraction Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Hospitals
8.3.1.2. Specialty Clinics
8.3.1.3. Stem Cell Banks/Laboratories
8.3.1.4. Others
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Stromal Vascular Fraction Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
8.4.1.2. GCC Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
8.4.1.3. GCC Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
8.4.1.4. South Africa Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
8.4.1.5. South Africa Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
8.4.1.6. South Africa Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
8.4.1.7. Egypt Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
8.4.1.8. Egypt Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
8.4.1.9. Egypt Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
8.4.1.10. Nigeria Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
8.4.1.11. Nigeria Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
8.4.1.12. Nigeria Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
8.4.1.13. Rest of Middle East & Africa Stromal Vascular Fraction Market by Product, Value (US$ Mn), 2018 - 2031
8.4.1.14. Rest of Middle East & Africa Stromal Vascular Fraction Market by Application, Value (US$ Mn), 2018 - 2031
8.4.1.15. Rest of Middle East & Africa Stromal Vascular Fraction Market by End User, Value (US$ Mn), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By Segment 3 vs by Application Heat map
9.2. Manufacturer vs by Application Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Cytori Therapeutics Inc.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. IntelliCell BioSciences Inc.
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Cellular Biomedicines Group, Inc.
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. GE Healthcare (Biosafe Group SA)
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Lifecell Corporation (Allergen PLC)
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Tissue Genesis Inc.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. InGeneron, Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Human med AG
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. MEDICAN CO., LTD
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Hairline International
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Genesis Biosystems, Inc.
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. iXCells Biotechnologies USA, LLC
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. Kyocera Corporation
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. Medikan International Inc
9.5.14.1. Company Overview
9.5.14.2. Product Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Cytori Therapeutics Inc
IntelliCell BioSciences Inc.
Cellular Biomedicines Group, Inc.
GE Healthcare (Biosafe Group SA)
Lifecell Corporation (Allergen PLC)
Tissue Genesis Inc.
InGeneron, Inc.
Human med AG
MEDICAN CO., LTD
Hairline International
Genesis Biosystems, Inc
iXCells Biotechnologies USA, LLC
Kyocera Corporation
Medikan International Inc

Methodology

LOADING...

Driving Growth: Development of Automated POC Devices

Challenges: Regulatory Compliance and Infrastructure

Country-wise Insights

United States: Extensive Clinical Trials Fuel Demand

India: Rise in Research and Development Activities

Germany: Musculoskeletal Disorders Drive Demand

Competitive Landscape

Key Companies in the Stromal Vascular Fraction (SVF) Market:

Key Segments Covered in Manufacturing of Industry Research

Product:

Application:

End User:

Region:

Table of Contents

Companies Mentioned (Partial List)

Methodology

Related Topics

Related Reports

Stromal Vascular Fraction - Global Strategic Business Report

Stromal Vascular Fraction Market Report: Trends, Forecast and Competitive Analysis to 2030

Global Stromal Vascular Fraction Market by Product (Aspiration, Isolation, Transfer), Application (Cosmetic, Orthopedic, Soft Tissue), End-Use - Forecast 2024-2030

Stromal Vascular Fraction Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

Animal Stem Cell Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)